Sections of this website
General section
Acne
Hidradenitis suppurativa (HS)
- decision-making tree
- context
- documentation
- definition
-
Diagnosis and evaluation
-
Medical care
-
Associated measures
-
Specific treatments
Epidemiology and contributing factors
Chronic Spontaneous Urticaria (CSU)
- decision-making tree guidelines
- guidelines table of contents
- context and objectives
- documentation
-
Diagnosis
-
Medical care
- treatment goal
- guidelines for adult
- guidelines for adult: first line treatment for adult
- guidelines for adult: stage 2 if failure of anti-H1 antihistamines
- guidelines for adult: stage 3 if failure of anti-H1 antihistamines (quadruple dose)
- guidelines for children under 12yo
- guidelines for children under 12yo, stage 1 first line treatment
- guidelines for children under 12yo, stage 2 second line treatment
- guidelines for children under 12yo, stage 3 third line treatment
- guidelines for pregnancy
- guidelines for pregnancy, stage 1 first line treatment
- guidelines for pregnancy, stage 2 second line treatment
-
Associated measures
-
Treatments
-
Clinical cases
Dynamique pas en test ni prod
- 404
- Centre of Evidence of Dermatology
- glossary
- help
- homepage
- how to read these guidelines
- sitemap
- sitemap
- terms and conditions
- algorithm
- algorithm
- all cold urticaria best practice guidelines
- all guidelines
- all hidradenitis suppurativa best practice guidelines
- anti-TNF treatment
- antibiotherapy treatment
- assessment of the severity
- associated measures
- associated measures
- associated measures
- associated measures in hidradenitis suppurativa
- benzyl benzoate
- bibliography
- bibliography
- breasfeeding woman
- child’s custody arrangement
- comorbidities and associated diseases
- comorbidities and associated diseases
- comorbidities treatments
- comorbidities, associated diseases
- context
- context and objective
- context and objectives
- context and objectives
- context and objectives
- contraception
- decision tree algorithm
- decision tree algorithm
- decision tree algorithm
- definition
- definition
- definition
- definition
- diagnosis
- diagnosis
- diagnosis
- diet and tobacco in hidradenitis suppurativa
- diet therapy
- documentation
- documentation
- documentation
- documentation
- documentation
- documentation
- elementary lesions
- elementary lesions of hidradenitis suppurativa
- epidemiological data
- epidemiology
- epidemiology
- epidemiology
- first line treatment for adult
- forms of scabies
- genetic factors
- guidelines for adult
- guidelines for children under 12yo
- guidelines for children under 12yo, stage 1 first line treatment
- guidelines for children under 12yo, stage 2 second line treatment
- guidelines for children under 12yo, stage 3 third line treatment
- guidelines for pregnancy
- guidelines for pregnancy, stage 1 first line treatment
- guidelines for pregnancy, stage 2 second line treatment
- guidelines table of contents
- gynecological
- hidradenitis suppurativa comorbidities
- hurley classification of hidradenitis suppurativa
- hygiene
- hygiene and local treatment
- immunosuppressive therapy treatment
- Indications de traitement systémique
- initial treatment
- initial treatment
- initial treatment
- initial treatment
- initial treatment
- laser-therapy / luminotherapy treatment
- localisation of lesions
- measures for breast milk
- medical care of follicular forms
- medical care of follicular forms, initial treatment
- medical care of follicular forms, treatment in cases of failure
- medical care of forms associated with inflammatory diseases
- medical care of Hidradenitis Suppurativa, Hurley stage 1, on relapse treatment
- medical care of Hidradenitis Suppurativa, Hurley stage 2, on relapse treatment
- medical care of of Hidradenitis Suppurativa follicular forms, on relapse treatment
- medical care, Hurley stage 1
- medical care, Hurley stage 1, initial treatment
- medical care, Hurley stage 1, treatment in cases of failure at 6 months
- medical care, Hurley stage 2, initial treatment
- medical care, Hurley stage 2, treatment in cases of failure at 6 months
- medical care, Hurley stage 3
- medical care, initial treatment
- medical care, on relapse treatment
- medical care, treatment in case of failure
- Mesures Associées pour tous les Patients
- modified Sartorius score
- next clinical case
- next clinical case
- next clinical case
- next clinical case
- next clinical case
- next clinical case
- next clinical case
- next clinical case
- next clinical case
- next clinical case
- next clinical case
- Omalizumab
- on relapse
- on relapse
- on relapse
- on relapse
- on relapse
- Options alternatives de traitement systémique
- Options de traitement systémique
- Options de traitement systémique
- Options de traitement systémique
- Options de traitement systémique
- Options de traitement systémique
- Options de traitement systémique
- Options de traitement systémique
- oral ivermectine
- pediatric
- permethrin
- physiopahtology
- physiopathology
- physiopathology
- physiopathology
- profuse scabies
- psychological support and pain management
- psychotherapeutic approaches
- quality of life
- Recherche de Comoridités pour tous les Patients
- retinoids treatment
- self-injectable adrenaline
- self-injectable adrenaline
- severity assessment
- Situations particulières : Adulte > 65 ans
- Situations particulières : Atteinte sévère prédominante des mains
- Situations particulières : Femme enceinte
- stage 2 if failure of anti-H1 antihistamines
- stage 3 if failure of anti-H1 antihistamines (quadruple dose)
- surgery treatment
- synthetic algorithm
- therapeutic education
- topical local treatments
- toutes les recommandations de bonnes pratiques pour la prise en charge de la dermatite atopique
- Traitement de Base pour tous les Patients
- Traitement des infections
- Traitement proactif en cas de récidives fréquentes
- Traitement topique de la poussée
- treatment goal
- treatment goals
- treatment goals
- treatment goals
- treatment with anti-H1 antihistamines
- treatment with anti-H2 antihistamines
- treatment with corticosteroids
- treatment with immunosuppresive therapy
- treatment with montelukast
- treatment with omalizumab
- treatment with other systemic treatments
